✦ LIBER ✦

Different serum concentrations of steady-state valproic acid in two sustained-release formulations

✍ Scribed by NORIO YASUI-FURUKORI; MANABU SAITO; TAKU NAKAGAMI; TAKENORI NIIOKA; YASUSHI SATO; AKIRA FUJII; SUNAO KANEKO

Book ID: 108962125
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 119 KB
Volume: 61
Category: Article
ISSN: 1323-1316
DOI: 10.1111/j.1440-1819.2007.01656.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative steady state serum levels of

Comparative steady state serum levels of valproic acid administered as two different formulations — Deprakine® and Orfiril®

✍ Svein I. Johannessen; Olaf Henriksen 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

Comparative Pharmacokinetics and Bioequi

Comparative Pharmacokinetics and Bioequivalence of Two Theophylline 300 MG Sustained Release Formulations at Oral Dosing Steady-State

✍ Dallas, P. P.; Gerogiannis, V. S.; Iliopoulos, T.; Markakis, N.; Pfeffer, M.; Ch 📂 Article 📅 1995 🏛 Informa plc 🌐 English ⚖ 382 KB

Absorption kinetics and steady-state pla

Absorption kinetics and steady-state plasma concentrations of theophylline following therapeutic doses of two sustained-release preparations

✍ O. Andersen; M. K. Nielsen; P. B. Eriksen; M. Fenger; P. J. Knudsen 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB

Single-Dose and Steady-State Pharmacokin

Single-Dose and Steady-State Pharmacokinetics of Diltiazem Administered in Two Different Tablet Formulations

✍ Christrup, Lona L. ;Bonde, Jan ;Rasmussen, Søren N. ;Sonnergaard, Jørn Møller ;J 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Components of variability in serum theop

Components of variability in serum theophylline concentrations during maintenance therapy with a sustained release formulation

✍ H. Halkin; A. Mazar; S. Almog; Y. Schnaps 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 589 KB

The use of Monte Carlo simulations to st

The use of Monte Carlo simulations to study the effect of poor compliance on the steady state concentrations of valproic acid following administration of enteric-coated and extended release divalproex sodium formulations

✍ Alaa M. Ahmad; F. Douglas Boudinot; William H. Barr; Ronald C. Reed; William R. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

## Abstract Divalproex sodium extended‐release (Depakote^®^ ER) is a once daily (QD) formulation for valproic acid that was developed to improve patient compliance and to reduce side effects compared with the standard twice‐daily (BID) delayed release (DR) formulation (Depakote^®^ tablets). However